ONGOING CLINICAL TRIAL: A PROSPECTIVE MULTICENTRE, PHASE 2B RANDOMISED, CONTROLLED DOUBLE-BLIND TRIAL TO DETERMINE THE SAFETY AND EFFICACY OF PERISPINAL ETANERCEPT ON QUALITY OF LIFE

被引：0
|
作者：
Thijs, V. [1 ]
Bernhardt, J. [1 ]
Cloud, G. [2 ]
Churilov, L. [3 ]
Sprigg, N. [4 ]
Parsons, B. [1 ]
Gilchrist, N. [5 ,6 ]
Walker, M. [6 ,7 ]
Bath, P. [7 ]
机构：
[1] Florey Inst Neurosci & Mental Hlth, Stroke Theme, Heidelberg, Vic, Australia
[2] Alfred Hlth, Stroke, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia
[4] Univ Nottingham, Sch Med, Stroke Trials Unit, Nottingham, England
[5] CGM Res Trust, Cgm, Christchurch, New Zealand
[6] Univ Nottingham UK, Div Rehabil Ageing & Wellbeing, Nottingham, England
[7] Nottingham Univ Hosp NHS Trust, Stroke, Dept Med, Nottingham, England
来源：
INTERNATIONAL JOURNAL OF STROKE | 2021年 / 16卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
WSC21-222
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [1] Ongoing clinical trial: PESTO, a prospective multicenter, phase 2b randomized controlled double-blind trial, to determine the safety and efficacy of perispinal etanercept on quality of life at 28 days post treatment
    Thijs, V
    Bernhardt, J.
    Churilov, L.
    Sprigg, N.
    Cloud, G.
    Parsons, B.
    Jafari, S.
    Walker, M.
    Gilchrist, N.
    Bath, P.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (1_SUPPL) : 30 - 30
  • [2] Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial
    Alexandrov, Andrei, V
    Kohrmann, Martin
    Soinne, Lauri
    Tsivgoulis, Georgios
    Barreto, Andrew D.
    Demchuk, Andrew M.
    Sharma, Vijay K.
    Mikulik, Robert
    Muir, Keith W.
    Brandt, Gordon
    Alleman, John
    Grotta, James C.
    Levi, Christopher R.
    Molina, Carlos A.
    Saqqur, Maher
    Mavridis, Dimitris
    Psaltopoulou, Theodora
    Vosko, Milan
    Fiebach, Jochen B.
    Mandava, Pitchaiah
    Kent, Thomas A.
    Alexandrov, Anne W.
    Schellinger, Peter D.
    LANCET NEUROLOGY, 2019, 18 (04): : 338 - 347
  • [3] Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial
    Brightling, Christopher E.
    Chanez, Pascal
    Leigh, Richard
    O'Byrne, Paul M.
    Korn, Stephanie
    She, Dewei
    May, Richard D.
    Streicher, Katie
    Ranade, Koustubh
    Piper, Edward
    LANCET RESPIRATORY MEDICINE, 2015, 3 (09): : 692 - 701
  • [4] Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
    Hanna, Michael G.
    Badrising, Umesh A.
    Benveniste, Olivier
    Lloyd, Thomas E.
    Needham, Merrilee
    Chinoy, Hector
    Aoki, Masashi
    Machado, Pedro M.
    Liang, Christina
    Reardon, Katrina A.
    de Visser, Marianne
    Ascherman, Dana P.
    Barohn, Richard J.
    Dimachkie, Mazen M.
    Miller, James A. L.
    Kissel, John T.
    Oskarsson, Bjoern
    Joyce, Nanette C.
    Van den Bergh, Peter
    Baets, Jonathan
    De Bleecker, Jan L.
    Karam, Chafic
    David, William S.
    Mirabella, Massimiliano
    Nations, Sharon P.
    Jung, Hans H.
    Pegoraro, Elena
    Maggi, Lorenzo
    Rodolico, Carmelo
    Filosto, Massimiliano
    Shaibani, Aziz, I
    Sivakumar, Kumaraswamy
    Goyal, Namita A.
    Mori-Yoshimura, Madoka
    Yamashita, Satoshi
    Suzuki, Naoki
    Katsuno, Masahisa
    Murata, Kenya
    Nodera, Hiroyuki
    Romano, Carla D.
    Williams, Valerie S. L.
    Vissing, John
    Auberson, Lixin Zhang
    Wu, Min
    de Vera, Ana
    Papanicolaou, Dimitris A.
    Amato, Anthony A.
    Nishino, Ichizo
    LANCET NEUROLOGY, 2019, 18 (09): : 834 - 844
  • [5] Safety and efficacy of eculizumab in Guillain-Barre syndrome: a multicentre, double-blind, randomised phase 2 trial
    Misawa, Sonoko
    Kuwabara, Satoshi
    Sato, Yasunori
    Yamaguchi, Nobuko
    Nagashima, Kengo
    Katayama, Kanako
    Sekiguchi, Yukari
    Iwai, Yuta
    Amino, Hiroshi
    Suichi, Tomoki
    Yokota, Takanori
    Nishida, Yoichiro
    Kanouchi, Tadashi
    Kohara, Nobuo
    Kawamoto, Michi
    Ishii, Junko
    Kuwahara, Motoi
    Suzuki, Hidekazu
    Hirata, Koichi
    Kokubun, Norito
    Masuda, Ray
    Kaneko, Juntaro
    Yabe, Ichiro
    Sasaki, Hidenao
    Kaida, Ken-ichi
    Takazaki, Hiroshi
    Suzuki, Norihiro
    Suzuki, Shigeaki
    Nodera, Hiroyuki
    Matsui, Naoko
    Tsuji, Shoji
    Koike, Haruki
    Yamasaki, Ryo
    Kusunoki, Susumu
    LANCET NEUROLOGY, 2018, 17 (06): : 519 - 529
  • [6] ICOSABUTATE IN NASH/MASH WITH FIBROSIS: RESULTS FROM A RANDOMISED, MULTICENTRE, DOUBLE-BLIND, PLACEBO CONTROLLED, PHASE 2b TRIAL (ICONA)
    Harrison, Stephen A.
    Alkhouri, Naim
    Benun, Jacques
    Ortiz-Lasanta, Grisell
    Rudraraju, Madhavi
    Steineger, Hilde H.
    Fraser, David
    Sanyal, Arun J.
    HEPATOLOGY, 2024, 79 (02) : E44 - E45
  • [7] Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial
    Tawil, Rabi
    Wagner, Kathryn R.
    Hamel, Johanna, I
    Leung, Doris G.
    Statland, Jeffrey M.
    Wang, Leo H.
    Genge, Angela
    Sacconi, Sabrina
    Lochmueller, Hanns
    Reyes-Leiva, David
    Diaz-Manera, Jordi
    Alonso-Perez, Jorge
    Muelas, Nuria
    Vilchez, Juan J.
    Pestronk, Alan
    Gibson, Summer
    Goyal, Namita A.
    Hayward, Lawrence J.
    Johnson, Nicholas
    LoRusso, Samantha
    Freimer, Miriam
    Shieh, Perry B.
    Subramony, S. H.
    van Engelen, Baziel
    Kools, Joost
    Leinhard, Olof Dahlqvist
    Widholm, Per
    Morabito, Christopher
    Moxham, Christopher M.
    Cadavid, Diego
    Mellion, Michelle L.
    Odueyungbo, Adefowope
    Tracewell, William G.
    Accorsi, Anthony
    Ronco, Lucienne
    Gould, Robert J.
    Shoskes, Jennifer
    Rojas, Luis Alejandro
    Jiang, John G.
    LANCET NEUROLOGY, 2024, 23 (05): : 477 - 486
  • [8] Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial
    King, Brett
    Zhang, Xingqi
    Harcha, Walter Gubelin
    Szepietowski, Jacek C.
    Shapiro, Jerry
    Lynde, Charles
    Mesinkovska, Natasha A.
    Zwillich, Samuel H.
    Napatalung, Lynne
    Wajsbrot, Dalia
    Fayyad, Rana
    Freyman, Amy
    Mitra, Debanjali
    Purohit, Vivek
    Sinclair, Rodney
    Wolk, Robert
    LANCET, 2023, 401 (10387): : 1518 - 1529
  • [9] Efficacy and Safety of Clonidine for the Treatment of Impulse Control Disorder in Parkinson's Disease: A Multicentre, Parallel, Randomised, Double Blind, Phase 2b Clinical Trial
    Laurencin, C.
    Marques, A.
    Duchez, D. Dilly
    Giordana, C.
    Meoni, S.
    Anheim, M.
    Boulinguez, P.
    Ballanger, B.
    Thobois, S.
    MOVEMENT DISORDERS, 2023, 38 : S35 - S36
  • [10] Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
    Cope, Andrew P.
    Jasenecova, Marianna
    Vasconcelos, Joana C.
    Filer, Andrew
    Raza, Karim
    Qureshi, Sumera
    D'Agostino, Maria Antonietta
    Mcinnes, Iain B.
    Isaacs, John
    Pratt, Arthur G.
    Fisher, Benjamin A.
    Buckley, Christopher
    Emery, Paul
    Ho, Pauline
    Buch, Maya H.
    Ciurtin, Coziana
    van Schaardenburg, Dirkjan
    Huizinga, Thomas
    Toes, Rene
    Georgiou, Evangelos
    Kelly, Joanna
    Murphy, Caroline
    Prevost, A. Toby
    LANCET, 2024, 403 (10429): : 838 - 849
12345